Literature DB >> 34532537

Purification of Soluble Recombinant Human Tau Protein from Bacteria Using Double-tag Affinity Purification.

Joseph McInnes1,2,3, Lujia Zhou1,2, And Patrik Verstreken1,2.   

Abstract

Dysfunction of the microtubule-associated protein Tau (encoded by the MAPT gene) has been implicated in more than twenty neurodegenerative diseases, including Alzheimer's. As such, the physiological and disease-relevant functions of Tau have garnered great interest in the research community. One barrier hampering investigations into the functions of Tau and the generation of pharmacological agents targeting Tau has been the difficulty of obtaining soluble Tau protein in purified form. Here, we describe a protocol that uses dual affinity tag purification to selectively purify soluble recombinant Tau protein from bacteria that is functionally active for downstream applications including immunization, microtubule binding assays, and protein-protein interaction studies.
Copyright © 2018 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Alzheimer’s; MAPT; Protein purification; Recombinant Tau; Soluble Tau; Tau

Year:  2018        PMID: 34532537      PMCID: PMC8342052          DOI: 10.21769/BioProtoc.3043

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  7 in total

1.  Electrophysiological changes precede morphological changes to frontal cortical pyramidal neurons in the rTg4510 mouse model of progressive tauopathy.

Authors:  Johanna L Crimins; Anne B Rocher; Jennifer I Luebke
Journal:  Acta Neuropathol       Date:  2012-09-14       Impact factor: 17.088

2.  Synaptogyrin-3 Mediates Presynaptic Dysfunction Induced by Tau.

Authors:  Joseph McInnes; Keimpe Wierda; An Snellinx; Laura Bounti; Yu-Chun Wang; Ilie-Cosmin Stancu; Nuno Apóstolo; Kris Gevaert; Ilse Dewachter; Tara L Spires-Jones; Bart De Strooper; Joris De Wit; Lujia Zhou; Patrik Verstreken
Journal:  Neuron       Date:  2018-02-01       Impact factor: 17.173

Review 3.  Tau and neurodegenerative disease: the story so far.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong
Journal:  Nat Rev Neurol       Date:  2015-12-04       Impact factor: 42.937

Review 4.  Tau in physiology and pathology.

Authors:  Yipeng Wang; Eckhard Mandelkow
Journal:  Nat Rev Neurosci       Date:  2015-12-03       Impact factor: 34.870

5.  Soluble pathological tau in the entorhinal cortex leads to presynaptic deficits in an early Alzheimer's disease model.

Authors:  Manuela Polydoro; Volodymyr I Dzhala; Amy M Pooler; Samantha B Nicholls; A Patrick McKinney; Laura Sanchez; Rose Pitstick; George A Carlson; Kevin J Staley; Tara L Spires-Jones; Bradley T Hyman
Journal:  Acta Neuropathol       Date:  2013-11-24       Impact factor: 17.088

6.  Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.

Authors:  David J Koss; Glynn Jones; Anna Cranston; Heidi Gardner; Nicholas M Kanaan; Bettina Platt
Journal:  Acta Neuropathol       Date:  2016-10-21       Impact factor: 17.088

7.  Tau association with synaptic vesicles causes presynaptic dysfunction.

Authors:  Lujia Zhou; Joseph McInnes; Keimpe Wierda; Matthew Holt; Abigail G Herrmann; Rosemary J Jackson; Yu-Chun Wang; Jef Swerts; Jelle Beyens; Katarzyna Miskiewicz; Sven Vilain; Ilse Dewachter; Diederik Moechars; Bart De Strooper; Tara L Spires-Jones; Joris De Wit; Patrik Verstreken
Journal:  Nat Commun       Date:  2017-05-11       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.